양세훈 교수 연구실
article|
green
·인용수 9
·2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea
Mi‐Hyun Kim, Chang‐Min Choi, Sung Yong Lee, Cheol‐Kyu Park, Yoon Soo Chang, Kye Young Lee, Seung Joon Kim, Sei Hoon Yang, Jeong‐Seon Ryu, Jeong Eun Lee, Shin Yup Lee, Chan Kwon Park, Sang Hoon Lee, Seung Hun Jang, Seong Hoon Yoon, Tae Won Jang
IF 2Anticancer Research
초록
Afatinib is effective in patients with NSCLC harboring major uncommon and compound EGFR mutations.
키워드
AfatinibT790MMedicineLung cancerEpidermal growth factor receptorInternal medicineOncologyExonMutationGastroenterology